Toggle navigation
Home
Search
Services
Blog
Contact
About
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
Johns Hopkins University, Baltimore, MD, United States
Search grants from Johns Hopkins University
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Nanobodies for topical delivery to inhibit abnormal choroidal angiogenesis
Surfactant Proteins and Respiratory Distress Syndrome
Outcomes of Sleep Disorders in Older Men
Molecular Biology and Function on Lens Proteins
I-Corps: A contactless, non-intrusive, artificial intelligence (AI)-enabled contact tracing system for reducing the spread of viruses
Recently added grants:
The role of UBXNs in antiviral immunity
Antimicrobial Synergy for Carbapenem-Resistant Enterobacteriaceae
Using agent-based modeling to estimate the effectiveness of the Miami Getting to Zero HIV campaign
The influence of evolutionary landscapes on protective antibody development
Human Vaccine Durability using Integrated Bioinformatics and a Novel in vitro Bone Marrow Mimic
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN995129-001
Application #
6994843
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Comments
Be the first to comment on this grant